24/7 BIOPHARMA | NEWSLETTER MAY 2026

DCAT https://youtu.be/JuFNMaNr2Hw Lonza and Oxford Nanopore Technologies Launch Direct RNA Sequencing Solution for GMP mRNA Quality Control Oxford Nanopore Technologies, a company delivering a new generation of nanoporebased molecular sensing technology, and Lonza today announced the launch of a new technology approach designed to modernize and accelerate GMP quality control testing for mRNA therapeutics. The solution combines direct RNA sequencing using nanopore technology with bespoke machine learningbased data analysis and customized software intended to help close the gap between the rapid pace of mRNA innovation and the slower evolution of analytical methods. mRNA therapeutics have... READ MORE

RkJQdWJsaXNoZXIy MjY2OTA4MA==